Aaron Ondrey, Chief Financial Officer at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,477 shares at $2.88 ($4K) on 2025-07-03, disclosed to the SEC on 2025-07-08.
Open-market sale of $4k RCKT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.